Ward Stephen C, Hamilton Bruce P, Hamlyn John M
Departments of Physiology and Medicine, School of Medicine, University of Maryland, and The Veterans Administration Medical Center, Baltimore, MD 21201, USA.
Hypertension. 2002 Feb;39(2 Pt 2):536-42. doi: 10.1161/hy0202.103048.
Sodium-potassium pumps (Na pumps) are the only known plasma membrane receptors for cardiac glycosides. However, adrenocortical cells secrete an endogenous ouabain via an unknown mechanism that is subject to feedback inhibition via the cell surface. In addition, recent studies suggest that the induction of sustained hypertension by ouabain analogs in rats may be independent of Na pump inhibition. Accordingly, we used bovine adrenocortical cells and membranes to search for novel binding sites for ouabain. In high extracellular potassium solutions, the binding of ouabain to the Na pumps of cultured cells was suppressed, yet residual specific binding of (3)H-ouabain was observed. In high extracellular potassium, Scatchard analyses revealed a novel class of ouabain binding sites with high affinity (<50 nmol/L, < 2.5 x 10(5) sites/cell) that was distinct from the low-affinity Na pump sites (>1 micromol/L, 4.5 x 10(6) sites/cell). Analysis of the kinetics for the dissociation of (3)H-ouabain from intact cells revealed components whose t(0.5) values were 6.5 minutes, 3.3 hours, and 33 hours and associated with novel sites, Na pumps, and lysosomal recycling, respectively. Studies with isolated membranes under ligand conditions where the participation of Na pumps was minimized revealed specific ouabain binding to novel sites that was saturable, time-dependent, of high affinity (K(d) approximately 15 nmol/L), and of low density (apparent B(max)=0.23 pmol/mg, c.f., Na pumps=10.2 pmol/mg). Ouabain binding to the novel sites was stimulated by high concentrations of KCl but was not affected by aldosterone or cortisol up to 30 micromol/L. Novel sites were not detected in skeletal muscle or liver membranes. Photoaffinity studies followed by SDS-PAGE showed ouabain-protectable labeling of membrane polypeptides with apparent molecular weights of 143, 113, and 65 kDa. We conclude that adrenocortical cells express ouabain receptors that are distinct from Na pumps. These novel receptors may be involved in the regulation and/or secretion of endogenous ouabain.
钠钾泵(Na泵)是已知的唯一能与强心苷结合的质膜受体。然而,肾上腺皮质细胞通过一种未知机制分泌内源性哇巴因,该机制受细胞表面的反馈抑制。此外,最近的研究表明,哇巴因类似物在大鼠中诱导持续性高血压可能与抑制Na泵无关。因此,我们使用牛肾上腺皮质细胞和细胞膜来寻找哇巴因的新结合位点。在高细胞外钾溶液中,哇巴因与培养细胞的Na泵结合受到抑制,但仍观察到(3)H-哇巴因的残留特异性结合。在高细胞外钾条件下,Scatchard分析揭示了一类新的哇巴因结合位点,其亲和力高(<50 nmol/L,<2.5×10(5)个位点/细胞),与低亲和力的Na泵位点(>1 μmol/L,4.5×10(6)个位点/细胞)不同。对(3)H-哇巴因从完整细胞解离的动力学分析显示,其组分的t(0.5)值分别为6.5分钟、3.3小时和33小时,分别与新位点、Na泵和溶酶体再循环相关。在使Na泵参与最小化的配体条件下对分离的细胞膜进行的研究表明,哇巴因与新位点的特异性结合是可饱和的、时间依赖性的、高亲和力的(K(d)约为15 nmol/L)且低密度的(表观B(max)=0.23 pmol/mg,相比之下,Na泵为10.2 pmol/mg)。高浓度的KCl刺激哇巴因与新位点的结合,但高达30 μmol/L的醛固酮或皮质醇对其无影响。在骨骼肌或肝细胞膜中未检测到新位点。光亲和研究后进行SDS-PAGE显示,哇巴因可保护标记表观分子量为143、113和65 kDa的膜多肽。我们得出结论,肾上腺皮质细胞表达与Na泵不同的哇巴因受体。这些新受体可能参与内源性哇巴因的调节和/或分泌。